Assignee
ASLAN PHARMACEUTICALS PTE LTD
SG·5 granted patents·19 pending applications·5 citations·filing 2016–2023
Top patents by PatentIndex Score
24 records- 0181US10357494B2Combination therapy comprising varlitinib and an anticancer agentASLAN PHARMACEUTICALS PTE LTD·Filed 2016·Granted Jul 23, 2019·4 cites·20 claims
- 0270US2023338356A1Treatment of autoimmune skin diseaseASLAN PHARMACEUTICALS PTE LTD·Filed 2023·Application pending·0 cites
- 0369US11382903B2Cancer therapyASLAN PHARMACEUTICALS PTE LTD·Filed 2018·Granted Jul 12, 2022·1 cites·13 claims
- 0466US2025262199A1Treatment of autoimmune skin diseaseASLAN PHARMACEUTICALS PTE LTD·Filed 2022·Application pending·0 cites
- 0565US10849899B2Combination therapy comprising Varlitinib and an anticancer agentASLAN PHARMACEUTICALS PTE LTD·Filed 2019·Granted Dec 1, 2020·0 cites·19 claims
- 0662US2025145570A1Dhodh inhibitor polymorphASLAN PHARMACEUTICALS PTE LTD·Filed 2023·Application pending·0 cites
- 0762US2026078192A1Treatment for sleep loss or sleep disturbance in patients with dermatitisASLAN PHARMACEUTICALS PTE LTD·Filed 2023·Application pending·0 cites
- 0861US2025163165A1Glycosylated form of anti-il13r antibodyASLAN PHARMACEUTICALS PTE LTD·Filed 2023·Application pending·0 cites
- 0961US2023002484A1TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Ra1 ANTIBODY OR BINDING FRAGMENT THEREOFASLAN PHARMACEUTICALS PTE LTD·Filed 2022·Application pending·0 cites
- 1061US2023091430A1TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Ra1 ANTIBODY OR BINDING FRAGMENT THEREOF IN AN ALLERGIC POPULATIONASLAN PHARMACEUTICALS PTE LTD·Filed 2022·Application pending·0 cites
- 1156US10682353B2Varlitinib for use in the treatment of resistant or refractory cancerASLAN PHARMACEUTICALS PTE LTD·Filed 2016·Granted Jun 16, 2020·0 cites·14 claims
- 1256US2025325475A1Anti-il-13r antibody formulationASLAN PHARMACEUTICALS PTE LTD·Filed 2022·Application pending·0 cites
- 1353US2021379070A1Malonate salt of varlitinibASLAN PHARMACEUTICALS PTE LTD·Filed 2019·Application pending·0 cites
- 1452US2025277042A1TREATMENT OF PRURITIS EMPLOYING ANTI-IL13Ra1 ANTIBODY OR BINDING FRAGMENT THEREOFASLAN PHARMACEUTICALS PTE LTD·Filed 2022·Application pending·0 cites
- 1552US2025002592A1Method for treatment of moderate to severe atopic dermatitisASLAN PHARMACEUTICALS PTE LTD·Filed 2022·Application pending·0 cites
- 1651US2023390276A1Treatment of autoimmune diseases with a dihydroorotate hehydrogenase (dhodh) inhibitorASLAN PHARMACEUTICALS PTE LTD·Filed 2021·Application pending·0 cites
- 1748US2021277131A1TREATMENT EMPLOYING ANTI-IL-l3R ANTIBODY OR BINDING FRAGMENT THEREOFASLAN PHARMACEUTICALS PTE LTD·Filed 2020·Application pending·0 cites
- 1847US2023355602A1Treatment and/or prevention of a viral infectionASLAN PHARMACEUTICALS PTE LTD·Filed 2021·Application pending·0 cites
- 1947US2022372125A1Antigen Specific Binding Domains and Antibody MoleculesASLAN PHARMACEUTICALS PTE LTD·Filed 2020·Application pending·0 cites
- 2044US11311548B2Cancer therapyASLAN PHARMACEUTICALS PTE LTD·Filed 2019·Granted Apr 26, 2022·0 cites·9 claims
- 2139US2019321365A1Maintenance Therapy for the Treatment of CancerASLAN PHARMACEUTICALS PTE LTD·Filed 2017·Application pending·0 cites
- 2237US2019134034A1Method of Treating Liver CancerASLAN PHARMACEUTICALS PTE LTD·Filed 2017·Application pending·0 cites
- 2334US2019117655A1Treatment of Biliary Duct CancerASLAN PHARMACEUTICALS PTE LTD·Filed 2018·Application pending·0 cites
- 2434US2020165347A1Method of treatment using il-13r antibodyASLAN PHARMACEUTICALS PTE LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ASLAN PHARMACEUTICALS PTE LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →